Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
347 participants
OBSERVATIONAL
2017-09-11
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To improve the awareness of unmet needs patient-reported outcome measurement has been the pivot of latest palliative care research. Besides the improvement of care outcome measurement allows the evaluation of the quality of palliative care and comparisons on a national and international level.
The aim of the present study is to evaluate the quality of palliative care in different settings (palliative care unit, inpatient and outpatient consultation teams) using the Integrated Palliative Care Outcome Scale (IPOS). The IPOS has been lately developed as improved follow-up version of the Palliative Care Outcome Scale (POS) integrating most important questions and simultaneously being brief and comprehensive. The study is planned as a multi-centric observational study. Primary endpoint is the reduction of symptom burden of patients.
The clinical study hypothesis bases on the assumption that palliative care can change the symptom burden, measured by a change in the IPOS overall profile score, and that there might be a difference in the size of the effect depending on the caring setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementing Spiritual Care in Inpatient Palliative Care
NCT06206551
Patient-centred Integrated Palliative Care Pathways in Advanced Cancer and Chronic Disease
NCT02175147
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic
NCT04910243
The Practice of Providing Palliative Care in the Situation of the COVID-19 Pandemic
NCT05089032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Meanwhile, a professional palliative caregiver completes a questionnaire about the main demographic aspects of the patients and assess the palliative care needs and the symptom burden using the IPOS.
After one week both, patient and professional palliative caregiver, will receive the same questionnaires again to assess the change from baseline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCU (unit)
Those patients who received specialised palliative care on a palliative care unit.(palliative care unit)
specialized palliative care
specialized palliative care provided in different settings
IPCC (hospital)
Those patients admitted to a regular hospital ward who received specialised palliative care from an inpatient palliative care consultation team.
(inpatient palliative care consultation team)
specialized palliative care
specialized palliative care provided in different settings
OPCC (outpatient)
Those patients who received specialised palliative care at home from an outpatient palliative care consultation team. (outpatient palliative care consultation team)
specialized palliative care
specialized palliative care provided in different settings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
specialized palliative care
specialized palliative care provided in different settings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years and older
Exclusion Criteria
* pregnant or breastfeeding women
* Inability to understand information for participation
* Refusal of participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Franziskus Hospital
OTHER
Raphaelsklinik Münster
UNKNOWN
Josephs Hospital Warendorf
UNKNOWN
Palliativnetz Muenster gGmbH
UNKNOWN
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital St. Raphael Muenster
Münster, North Rhine-Westphalia, Germany
Hospital St. Franziskus Muenster
Münster, North Rhine-Westphalia, Germany
University Hospital Muenster
Münster, North Rhine-Westphalia, Germany
Palliativnetz Muenster
Münster, North Rhine-Westphalia, Germany
Hospital St. Josef Warendorf
Warendorf, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UKM_POEM I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.